As the disease enters these phases, upregulation of pro-inflammatory mediators like CXCL10 become predictive of the clinical course and approximately 20% of these patients go on to develop acute respiratory distress syndrome (ARDS) [1]. The gene discussed is CXCL10; the disease is acute respiratory distress syndrome.